DJ-1/park7 modulates vasorelaxation and blood pressure via epigenetic modification of endothelial nitric oxide synthase.

AIMS DJ-1/park7, a multifunctional protein, may play essential roles in the vascular system. However, the function of DJ-1/park7 in vascular contractility has remained unclear. The present study was designed to investigate whether the DJ-1/park7 is involved in the regulation of vascular contractility and systolic blood pressure (SBP). METHODS AND RESULTS Norepinephrine (NE) elevated contraction in endothelium-intact vessels in a dose-dependent manner, to a greater extent in DJ-1/park7 knockout (DJ-1/park7(-/-)) mice than in wild-type (DJ-1/park7(+/+)) mice. Acetylcholine inhibited NE-evoked contraction in endothelium-intact vessels, and this was markedly impaired in DJ-1/park7(-/-) mice compared with DJ-1/park7(+/+). Nitric oxide (NO) production (82.1 ± 2.8% of control) and endothelial NO synthase (eNOS) expression (61.7 ± 8.9%) were lower, but H2O2 production (126.4 ± 8.6%) was higher, in endothelial cells from DJ-1/park7(-/-) mice than in those from DJ-1/park7(+/+) controls; these effects were reversed by DJ-1/park7-overexpressing endothelial cells from DJ-1/park7(-/-) mice. Histone deacetylase (HDAC)-1 recruitment and H3 histone acetylation at the eNOS promoter were elevated and diminished, respectively, in DJ-1/park7(-/-) mice compared with DJ-1/park7(+/+) controls. Moreover, SBP was significantly elevated in DJ-1/park7(-/-) mice compared with DJ-1/park7(+/+) controls, but this elevation was inhibited in mice treated with valproic acid, an inhibitor of Class I HDACs including HDAC-1. CONCLUSION These results demonstrate that DJ-1/park7 protein may be implicated in the regulation of vascular contractility and blood pressure, probably by the impairment of NO production through H2O2-mediated epigenetic inhibition of eNOS expression.

[1]  Bokyung Kim,et al.  DJ-1 regulates mast cell activation and IgE-mediated allergic responses. , 2013, The Journal of allergy and clinical immunology.

[2]  Chang-Kwon Lee,et al.  DJ-1/park7 protects against neointimal formation via the inhibition of vascular smooth muscle cell growth. , 2013, Cardiovascular research.

[3]  T. McKinsey,et al.  Histone Deacetylation Inhibition in Pulmonary Hypertension: Therapeutic Potential of Valproic Acid and Suberoylanilide Hydroxamic Acid , 2012, Circulation.

[4]  Hae-Ahm Lee,et al.  Tissue-Specific Upregulation of Angiotensin-Converting Enzyme 1 in Spontaneously Hypertensive Rats Through Histone Code Modifications , 2012, Hypertension.

[5]  I. Armando,et al.  Role of Renal DJ-1 in the Pathogenesis of Hypertension Associated With Increased Reactive Oxygen Species Production , 2012, Hypertension.

[6]  K. Kang,et al.  Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3 , 2012, Tumor Biology.

[7]  J. Raffetto,et al.  Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. , 2011, American journal of physiology. Heart and circulatory physiology.

[8]  L. Tsai,et al.  Epigenetic regulation of gene expression in physiological and pathological brain processes. , 2011, Physiological reviews.

[9]  N. Mariappan,et al.  HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive Rats , 2010, Hypertension.

[10]  T. Lüscher,et al.  Human endothelial dysfunction: EDRFs , 2010, Pflügers Archiv - European Journal of Physiology.

[11]  F. Fitzpatrick,et al.  Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function* , 2010, The Journal of Biological Chemistry.

[12]  T. Michel,et al.  Cellular signaling and NO production , 2010, Pflügers Archiv - European Journal of Physiology.

[13]  Young Shik Park,et al.  Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels , 2009, Proteomics.

[14]  B. Jeon,et al.  Gene Transfer of Redox Factor-1 Inhibits Neointimal Formation: Involvement of Platelet-Derived Growth Factor-&bgr; Receptor Signaling via the Inhibition of the Reactive Oxygen Species–Mediated Syk Pathway , 2009, Circulation research.

[15]  Yan Zhu,et al.  High blood pressure arising from a defect in vascular function , 2008, Proceedings of the National Academy of Sciences.

[16]  K. Griendling,et al.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. , 2007, Trends in cardiovascular medicine.

[17]  K. Won,et al.  Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle , 2006, Proteomics.

[18]  J. Catravas,et al.  Nitric oxide and the endothelium: history and impact on cardiovascular disease. , 2006, Vascular pharmacology.

[19]  C. Searles.  Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. , 2006, American journal of physiology. Cell physiology.

[20]  T. Mak,et al.  DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 , 2006, Proceedings of the National Academy of Sciences.

[21]  J. Gunnet,et al.  Enhancement of arachidonic acid signaling pathway by nicotinic acid receptor HM74A. , 2006, Biochemical and biophysical research communications.

[22]  S. Blackburn.  Free radicals in perinatal and neonatal care, part 2: oxidative stress during the perinatal and neonatal period. , 2006, The Journal of perinatal & neonatal nursing.

[23]  G. Fink,et al.  Pleiotropic Effects of Hydrogen Peroxide in Arteries and Veins From Normotensive and Hypertensive Rats , 2006, Hypertension.

[24]  J. Coselli,et al.  Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. , 2006, Biochemical and biophysical research communications.

[25]  K. Rockett,et al.  Stoichiometric Relationships Between Endothelial Tetrahydrobiopterin, Endothelial NO Synthase (eNOS) Activity, and eNOS Coupling in Vivo: Insights From Transgenic Mice With Endothelial-Targeted GTP Cyclohydrolase 1 and eNOS Overexpression , 2005, Circulation research.

[26]  H. Cai.  Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. , 2005, Cardiovascular research.

[27]  J. Fish,et al.  The Expression of Endothelial Nitric-oxide Synthase Is Controlled by a Cell-specific Histone Code* , 2005, Journal of Biological Chemistry.

[28]  David S. Park,et al.  Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Wedgwood,et al.  Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[30]  Junghwan Kim,et al.  p38 Mitogen-Activated Protein Kinase Contributes to the Diminished Aortic Contraction by Endothelin-1 in DOCA-Salt Hypertensive Rats , 2004, Hypertension.

[31]  R. Busse,et al.  Valproic acid inhibits angiogenesis in vitro and in vivo. , 2004, Molecular pharmacology.

[32]  T. Niki,et al.  DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.

[33]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[34]  U. Förstermann,et al.  Inhibitors of Histone Deacetylation Downregulate the Expression of Endothelial Nitric Oxide Synthase and Compromise Endothelial Cell Function in Vasorelaxation and Angiogenesis , 2002, Circulation research.

[35]  A. Dorrance,et al.  NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat , 2001, Hypertension.

[36]  Ernesto L. Schiffrin,et al.  Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis , 2001, Hypertension.

[37]  D. Moura,et al.  Vascular adrenoceptors: an update. , 2001, Pharmacological reviews.

[38]  T. Taira,et al.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. , 1997, Biochemical and biophysical research communications.

[39]  J. Jukema,et al.  Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[40]  Ernesto L. Schiffrin,et al.  Endothelial dysfunction. , 2004, Journal of the American Society of Nephrology : JASN.

[41]  D. Kereiakes,et al.  Endothelial dysfunction. , 2003, Circulation.